C
ertain populations, such as the elderly and people with chronic illnesses, are at increased risk from influenza and Streptococcus pneumoniae infection and subsequent complications. 1, 2 Despite advances in medical treatment, immunization with influenza and pneumococcal vaccines remains the primary strategy for preventing infections in high-risk populations. Also important in this era of drugresistant strains of S. pneumoniae is that the 23-valent pneumococcal polysaccharide vaccine represents 85-90% of the disease-causing serotypes of the bacterium and includes antigens from the six serotypes that exhibit drug resistance and frequently cause invasive disease. [3] [4] [5] Despite the efficacy of vaccines in the prevention of influenza and pneumococcal infection and subsequent complications, a significant number of high-risk patients remain unvaccinated. In 1999, 66.9% of Americans older than 65 years had ever received the influenza vaccine, while only 54.1% of those older than 65 years reported ever receiving the pneumococcal vaccine. 6 In addition, immunization rates varied among ethnic groups, with lower rates among Hispanics and blacks. As a result, the Public Health Service has set national health objectives to increase influenza and pneumococcal immunization rates in high-risk populations to greater than 60% in 2000 and greater than 90% by 2010. 7 While outpatient vaccination opportunities are commonly promoted, opportunities in inpatient settings are often overlooked. Failure to target high-risk patients for immunization during hospitalization should be considered a missed opportunity for the prevention of future morbidity and mortality due to influenza and pneumococcal infection. Two thirds of patients hospitalized for pneumococcal bacteremia have been hospitalized in the previous five years. [8] [9] [10] A recent survey of Medicare records found that only 0.4% and 1.9% of patients were immunized with influenza and pneumococcal vaccines, respectively, during their hospital stay. 11 Various strategies have been used to improve immunization rates among adults who are candidates for influenza or pneumococcal vaccine. Immunization programs targeting hospitalized patients have utilized chart reminders to physicians, flagged charts identifying high-risk patients, and provided vaccination standing orders completed by non-Am J Health-Syst Pharm-Vol 60 Sep 1, 2003 physicians for eligible patients. 9, 10, [12] [13] [14] [15] [16] [17] [18] [19] The Centers for Disease Control and Prevention (CDC) has advocated both inpatient immunization and the use of standing orders to increase vaccination rates among high-risk individuals. 20, 21 The purpose of this study was to determine the effect of a pharmacistmanaged program of pneumococcal and influenza immunization utilizing standing orders on vaccination rates among high-risk adult inpatients at a university teaching hospital.
Methods. The study was conducted from January 2 to February 28, 2001, at the University of North Carolina Hospitals, a 684-bed public teaching hospital. All adults greater than 18 years of age who were admitted to the general medicine, pulmonary medicine, and infectious diseases services were included in the intervention group and were considered for immunization. All patients admitted to the renal and gastrointestinal medicine, cardiology, and family medicine services were included in the control group. Control patients were not actively targeted by pharmacists for immunization but were immunized if this was ordered by the health care provider during usual care.
For patients in the intervention group, a pharmacist assigned to the medical service identified new admissions from daily census reports and screened the patients for indications for influenza and pneumococcal immunization according to the guidelines of the Advisory Committee on Immunization Practices (ACIP). 1, 2 Pharmacists' participation in the vaccination program was voluntary. Initial information was retrieved from the inpatient medical chart and online medical record. Interviews were conducted by the pharmacist for patients with indications for immunization to determine possible contraindications, to determine vaccination status, and to provide education. During the interview, patients were provided with vaccine information sheets published by CDC. 22, 23 Contraindications to influenza and pneumococcal vaccination by standing order are listed in Table  1 . Because of difficulty in obtaining documentation of prior immunizations, vaccination status was determined by patient recall alone. For patients unsure of their vaccination status, immunization with influenza or pneumococcal vaccine was recommended in accordance with ACIP guidelines.
1,2 For patients at risk of complications from intramuscular injections (e.g., anticoagulation, thrombocytopenia), the decision to immunize was discussed with the physician, and subsequent vaccination occurred under a physician order rather than a standing order.
Vaccination standing orders were completed by the pharmacist for patients who had indications for vaccination, who had no contraindications, and who were agreeable to vaccination. A short form noting the pharmacist's intervention, including the vaccine ordered or the reason for not ordering a vaccine, was completed and placed in the patient's chart. Patients receiving vaccines during hospitalization were given a wallet card upon discharge with documentation of the vaccines administered and the dates of vaccination.
The following data were collected for the intervention group: number of weekday admissions to each service, number of patients screened by a pharmacist, number of high-risk patients with indications for immunization with pneumococcal or influenza vaccine, number of patients with specific contraindications to immunization (not including prior vaccination), number of patients reporting prior vaccination, and number of patients who were vaccinated during the current hospitalization. The following data were collected for the control group: number of weekday admissions to each service, number of high-risk patients with indications for immunization with pneumococcal or influenza vaccine, and number of patients who were vaccinated during the current hospitalization. Pertinent information for patients in the control group was retrieved from daily census reports, medication reports, and online medical records.
Data for both groups were compared by using chi-square analysis (SPSS for Windows, version 10.0, SPSS Inc., Chicago, IL). The study was approved by the institutional review board at the University of North Carolina Hospitals. The a priori level of significance was 0.05.
Results. During the study period, a total of 542 and 761 patients were entered into the intervention and control groups, respectively. The Other reasons for not receiving pneumococcal vaccination were previous severe reaction to vaccination (one patient), radiation therapy within the previous two weeks (one), and desire to have a primary care provider vaccinate (eight). Reasons for not receiving influenza vaccination were previous severe reaction (two patients), contraindication to intramuscular injection (three), egg allergy (one), radiation therapy within the previous two weeks (one), and desire to have a primary care provider vaccinate (five).
Less than 1% of all patients in the control group with indications for immunization received pneumococcal or influenza vaccine during hos- 9,10 A recent study involving 16 hospitals found that inclusion of reminders for pneumococcal vaccination in a clinical pathway increased the pneumococcal immunization rate only trivially: from 1.1% to 1.3%.
11
While interventions reminding or alerting health care providers to vaccinate certain individuals may increase immunization rates, the increases appear to be modest compared with those achieved by standing orders. One study evaluating the effect of standing orders completed by emergency department nurses found influenza and pneumococcal immunization rates of 62% and 34%, respectively, among previously nonimmunized, eligible patients. 12 Another study of standing orders for pneumococcal vaccination completed by an infection-control nurse observed an immunization rate of 78%. 13 In our study, approximately 71% and 55% of screened, eligible patients in the intervention group were given pneumococcal and influenza vaccines, respectively.
A significant percentage of patients in both the control and intervention groups (80-88%) had one or more indications for immunization with influenza or pneumococcal vaccine. These percentages are comparable to those reported elsewhere (40-81%). 9, 10, 13, 17 Substantial percentages of patients in our intervention group reported having received pneumococcal or influenza vaccine prior to hospitalization. In 1999 in North Carolina, 64.2% of persons older than 65 years reported having received the influenza vaccine in the past year, while 58.5% of persons older than 65 years had ever received the pneumococcal vaccine. 6 Immunization rates among patients younger than 65 years with chronic illnesses are typically much lower.
Our study is limited by a lack of consistent documentation of immunization history and dependence on patient recall. It is possible that patients may have incorrectly recalled being vaccinated or confused previous administration of influenza and pneumococcal vaccines. Therefore, the percentage of patients reporting prior vaccination may have been falsely elevated. Patients who were unable to recall prior vaccination or who were unsure of their vaccination status were recommended for inpatient immunization in accordance with ACIP recommendations.
1,2 Previous studies have shown that revaccination with pneumococcal and influenza vaccines is safe, although there may be a slightly increased risk of injection-site reactions.
1,2 Our study did not measure adverse effects resulting from vaccination, but no reports of adverse reactions to pneumococcal or influenza vaccine were reported among the patients during their hospitalization.
A small percentage of patients refused vaccination. Common reasons for refusal in our study included fear of adverse reactions and underestimation of the importance of vaccination. The pharmacist screening for immunization status educated patients about the importance of vaccination and addressed their concerns. A few patients preferred not to receive vaccines while hospitalized and instead desired to have their primary care provider vaccinate them later. We did not follow up these patients to see if they did receive the vaccines after discharge.
Another concern regarding vaccination of patients during hospitalization is proper communication of such vaccinations to primary care providers and outpatient clinics. Options for ensuring communication and documentation of inpatient vaccinations in our program included wallet cards supplied to patients upon discharge documenting dates and individual vaccines, transmission of vaccination documentation to clinician offices by mail or fax, and documentation of vaccination on electronic medical records. When our program was implemented, it was determined that transmission of vaccination documentation was not only labor-intensive but not feasible for patients without primary care providers. Also, there was no central location for documentation of immunization history on electronic medical records so that clinicians could determine if a patient had been vaccinated while hospitalized. As a result, documentation of vaccinations consisted of administration records in the inpatient chart and wallet cards given to patients upon discharge. Lack of a central location for immunization data that was easily accessible to both inpatient and outpatient clinicians has prompted our institution to begin creating an immunization history file in electronic medical records.
The vaccination standing orders were generally well received by medical house staff and pharmacists. Overall, the medical house staff believed that the standing orders provided a useful service for patients. When asked if they routinely inquired about vaccination status or considered vaccines for hospitalized patients, many house staff physicians said they were unsure about current immunization guidelines or unsure about the immunization status of their patients. Alternatively, they believed that there were more important clinical issues to address during hospitalization or that vaccination was an outpatient issue.
Only 47% of patients enrolled in the intervention group were screened by a pharmacist for indications for vaccination. The percentage of newly admitted patients screened each day varied with the pharmacist on duty and the clinical service unit and ranged from 0% to 88%. Pharmacists covering smaller service units and those incorporating screening into daily clinical activities accounted for the higher screening rates. The most common reason cited by the pharmacists for failure to screen patients was lack of time. While the number of screened patients was lower than desired, our pharmacists, by screening only half of the patients entered into the intervention group over two months, were responsible for 66 pneumococcal vaccination orders and 47 influenza vaccination orders. In contrast, of patients in the control group who were not screened by a pharmacist, only three received pneumoccoccal vaccine and five influenza vaccine.
Conclusion. A pharmacistmanaged immunization program for adult inpatients significantly increased vaccination rates among patients at high risk for influenza and pneumococcal infection. However, adequate resources such as an increased number of clinical pharmacists involved in screening on each service or a designated team of pharmacists responsible for all screening are required to ensure success of such a program.
